Article,

Bihormonal fully closed-loop system for the treatment of type 1 diabetes: a real-world multicentre, prospective, single-arm trial in the Netherlands

, , , , , , , , , , , , , , , , , and .
The Lancet Digital Health, (2024)
DOI: 10.1016/S2589-7500(24)00002-5

Abstract

BackgroundManagement of insulin administration for intake of carbohydrates and physical activity can be burdensome for people with type 1 diabetes on hybrid closed-loop systems. Bihormonal fully closed-loop (FCL) systems could help reduce this burden. In this trial, we assessed the long-term performance and safety of a bihormonal FCL system.

Tags

Users

  • @tabularii

Comments and Reviews